Legis Daily

To amend title XI of the Social Security Act to clarify manufacturer transparency reporting requirements for certain transfers used for educational purposes.

USA118th CongressHR-4402| House 
| Updated: 12/17/2024
Michael C. Burgess

Michael C. Burgess

Republican Representative

Texas

Cosponsors (1)
Ami Bera (Democratic)

Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
This bill specifies that manufacturers of drugs, devices, biologics, or medical supplies covered by Medicare, Medicaid or the Children's Health Insurance Program (CHIP) are not required to report peer-reviewed journals, journal reprints, journal supplements, medical conference reports, or medical textbooks that are provided to health care practitioners or teaching hospitals.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jun 30, 2023
Introduced in House
Jun 30, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 7, 2023
Referred to the Subcommittee on Health.
Dec 17, 2024
Referred to the Subcommittee on Health.
  • June 30, 2023
    Introduced in House
  • June 30, 2023
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • July 7, 2023
    Referred to the Subcommittee on Health.
  • December 17, 2024
    Referred to the Subcommittee on Health.

Health

Health technology, devices, suppliesManufacturingMedicaidMedicarePoverty and welfare assistancePrescription drugs

To amend title XI of the Social Security Act to clarify manufacturer transparency reporting requirements for certain transfers used for educational purposes.

USA118th CongressHR-4402| House 
| Updated: 12/17/2024
This bill specifies that manufacturers of drugs, devices, biologics, or medical supplies covered by Medicare, Medicaid or the Children's Health Insurance Program (CHIP) are not required to report peer-reviewed journals, journal reprints, journal supplements, medical conference reports, or medical textbooks that are provided to health care practitioners or teaching hospitals.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jun 30, 2023
Introduced in House
Jun 30, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 7, 2023
Referred to the Subcommittee on Health.
Dec 17, 2024
Referred to the Subcommittee on Health.
  • June 30, 2023
    Introduced in House
  • June 30, 2023
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • July 7, 2023
    Referred to the Subcommittee on Health.
  • December 17, 2024
    Referred to the Subcommittee on Health.
Michael C. Burgess

Michael C. Burgess

Republican Representative

Texas

Cosponsors (1)
Ami Bera (Democratic)

Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Health technology, devices, suppliesManufacturingMedicaidMedicarePoverty and welfare assistancePrescription drugs